These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 24418633)

  • 1. Risks, prices, and positions: A social network analysis of illegal drug trafficking in the world-economy.
    Boivin R
    Int J Drug Policy; 2014 Mar; 25(2):235-43. PubMed ID: 24418633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cocaine and heroin markets in the era of globalisation and drug reduction policies.
    Costa Storti C; De Grauwe P
    Int J Drug Policy; 2009 Nov; 20(6):488-96. PubMed ID: 19447024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the structure and operation of drug supply chains: The case of cocaine and heroin in Italy and Slovenia.
    Caulkins JP; Disley E; Tzvetkova M; Pardal M; Shah H; Zhang X
    Int J Drug Policy; 2016 May; 31():64-73. PubMed ID: 26997542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Should I Buy or Should I Grow?" How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic.
    Belackova V; Maalsté N; Zabransky T; Grund JP
    Int J Drug Policy; 2015 Mar; 26(3):296-310. PubMed ID: 25655217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug affordability-potential tool for comparing illicit drug markets.
    Groshkova T; Cunningham A; Royuela L; Singleton N; Saggers T; Sedefov R
    Int J Drug Policy; 2018 Jun; 56():187-196. PubMed ID: 29459212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Globalization and the price decline of illicit drugs.
    Costa Storti C; De Grauwe P
    Int J Drug Policy; 2009 Jan; 20(1):48-61. PubMed ID: 18272358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ethnographic exploration of drug markets in Kisumu, Kenya.
    Syvertsen JL; Ohaga S; Agot K; Dimova M; Guise A; Rhodes T; Wagner KD
    Int J Drug Policy; 2016 Apr; 30():82-90. PubMed ID: 26838470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Price elasticity of illegal versus legal cannabis: a behavioral economic substitutability analysis.
    Amlung M; Reed DD; Morris V; Aston ER; Metrik J; MacKillop J
    Addiction; 2019 Jan; 114(1):112-118. PubMed ID: 30194789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying Demand Responses to Illegal Drug Supply Interdictions.
    Cunningham S; Finlay K
    Health Econ; 2016 Oct; 25(10):1268-90. PubMed ID: 26216390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for a risky business: How drug dealers manage customers, suppliers and competitors in Italy, Slovenia and Germany.
    Tzvetkova M; Pardal M; Disley E; Rena A; Talic S; Forberger S
    Int J Drug Policy; 2016 May; 31():90-8. PubMed ID: 27161385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illegal drug market responses to state recreational cannabis laws.
    Meinhofer A; Rubli A
    Addiction; 2021 Dec; 116(12):3433-3443. PubMed ID: 33998087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The socioeconomic impact of drug-related crimes in Chile.
    Fernández M
    Int J Drug Policy; 2012 Nov; 23(6):465-72. PubMed ID: 22608568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An island apart? Risks and prices in the Australian cryptomarket drug trade.
    Cunliffe J; Martin J; Décary-Hétu D; Aldridge J
    Int J Drug Policy; 2017 Dec; 50():64-73. PubMed ID: 29055855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of law enforcement activity on a heroin market.
    Weatherburn D; Lind B
    Addiction; 1997 May; 92(5):557-69; discussion 611-3. PubMed ID: 9219378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data.
    Moeller K; Munksgaard R; Demant J
    Int J Drug Policy; 2021 May; 91():102969. PubMed ID: 33041184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of cocaine and heroin price on drug-related emergency department visits.
    Dave D
    J Health Econ; 2006 Mar; 25(2):311-33. PubMed ID: 16188336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-threshold methadone treatment, heroin price, police activity and incidence of heroin use: the Zurich experience.
    Nordt C; Stohler R
    Int J Drug Policy; 2009 Nov; 20(6):497-501. PubMed ID: 19349154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncertainty and risk: A framework for understanding pricing in online drug markets.
    Munksgaard R; Tzanetakis M
    Int J Drug Policy; 2022 Mar; 101():103535. PubMed ID: 34902806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The temporal relationship between drug supply indicators: an audit of international government surveillance systems.
    Werb D; Kerr T; Nosyk B; Strathdee S; Montaner J; Wood E
    BMJ Open; 2013 Sep; 3(9):e003077. PubMed ID: 24080093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating explanations of the Australian 'heroin shortage'.
    Degenhardt L; Reuter P; Collins L; Hall W
    Addiction; 2005 Apr; 100(4):459-69. PubMed ID: 15784060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.